(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol

C31H56O3Si — CID 174028181

IUPAC(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
SMILESCC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H](C/C=C/CO)CC[C@@H]23)[C@@]2(C)CCC(O[Si](C)(C)C(C)(C)C)C[C@@H]12
InChIInChI=1S/C31H56O3Si/c1-9-23-26-20-22(34-35(7,8)29(2,3)4)15-17-31(26,6)25-16-18-30(5)21(12-10-11-19-32)13-14-24(30)27(25)28(23)33/h10-11,21-28,32-33H,9,12-20H2,1-8H3/b11-10+/t21-,22?,23+,24-,25-,26-,27-,28+,30+,31+/m0/s1
InChIKeyVJQJRLIOSDAPHC-VYDCBXTASA-N
MW504.87 g/mol
LogP7.58
Rot. Bonds6

About (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol

(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol (PubChem CID 174028181) has the molecular formula C31H56O3Si and a molecular weight of 504.87 g/mol. Its IUPAC name is (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol.

Molecular Properties

Compound Name(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
PubChem CID174028181
Molecular FormulaC31H56O3Si
Molecular Weight504.87 g/mol
Exact Mass504.40
IUPAC Name(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
SMILESCC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H](C/C=C/CO)CC[C@@H]23)[C@@]2(C)CCC(O[Si](C)(C)C(C)(C)C)C[C@@H]12
InChIInChI=1S/C31H56O3Si/c1-9-23-26-20-22(34-35(7,8)29(2,3)4)15-17-31(26,6)25-16-18-30(5)21(12-10-11-19-32)13-14-24(30)27(25)28(23)33/h10-11,21-28,32-33H,9,12-20H2,1-8H3/b11-10+/t21-,22?,23+,24-,25-,26-,27-,28+,30+,31+/m0/s1
InChIKeyVJQJRLIOSDAPHC-VYDCBXTASA-N
XLogP7.58
TPSA49.69 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500504.87
LogP ≤ 57.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol?
The IUPAC name of (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol (CID 174028181) is (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol.
What is the SMILES notation for (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol?
The canonical SMILES for (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol is CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H](C/C=C/CO)CC[C@@H]23)[C@@]2(C)CCC(O[Si](C)(C)C(C)(C)C)C[C@@H]12.
What is the InChIKey of (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol?
The InChIKey is VJQJRLIOSDAPHC-VYDCBXTASA-N. The full InChI is InChI=1S/C31H56O3Si/c1-9-23-26-20-22(34-35(7,8)29(2,3)4)15-17-31(26,6)25-16-18-30(5)21(12-10-11-19-32)13-14-24(30)27(25)28(23)33/h10-11,21-28,32-33H,9,12-20H2,1-8H3/b11-10+/t21-,22?,23+,24-,25-,26-,27-,28+,30+,31+/m0/s1.
What are the key properties of (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol?
(5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol has a molecular weight of 504.87 g/mol, XLogP of 7.58, 6 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (5S,6R,7R,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-6-ethyl-17-[(E)-4-hydroxybut-2-enyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol is sourced from PubChem (CID 174028181), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).